US BROKER MOVES: CRI upgraded at Wells Fargo; ZGN downgraded at Goldman Sachs

UPGRADES

• Credicorp (BAP) Upgraded to Overweight at Morgan Stanley; PT USD 480 (prev USD 375)
• Carter’s (CRI) Upgraded to Equalweight at Wells Fargo; PT USD 42 (prev USD 30)
• Charles River Laboratories (CRL) Upgraded to Overweight at Morgan Stanley; PT USD 220 (prev USD 185)
• Macerich (MAC) Upgraded to Neutral at JPMorgan; PT USD 25 (prev USD 23)
• MFA Financial (MFA) Upgraded to Buy at BTIG; PT USD 10.50
• AG Mortgage Investment Trust (MITT) Upgraded to Buy at BTIG; PT USD 9
• Wabash National (WNC) Upgraded to Buy at DA Davidson

DOWNGRADES

• Cognizant (CTSH) Downgraded to Hold at Berenberg; PT USD 59 (prev USD 81)
• IQVIA (IQV) Downgraded to Equalweight at Morgan Stanley; PT USD 200 (prev USD 225)
• Leidos (LDOS) Downgraded to Neutral at BofA Securities; PT USD 125 (prev USD 200)
• Rexford Industrial Realty (REXR) Downgraded to Underweight at JPMorgan; PT USD 36 (prev USD 38)
• ResMed (RMD) Downgraded to Equalweight at Morgan Stanley; PT USD 230 (prev USD 286)
• Grupo Televisa (TV) Downgraded to Reduce at New Street Research; PT USD 2.20
• Zegna (ZGN) Downgraded to Neutral at Goldman Sachs; PT USD 14 (prev USD 13.30)

INITIATIONS

• Allegiant Travel (ALGT) Initiated Buy at Goldman Sachs; PT USD 125
• Middleby (MIDD) Initiated Outperform at Oppenheimer; PT USD 205
• Onto Innovation (ONTO) Initiated Buy at Freedom Broker; PT USD 370
• Tyra Biosciences (TYRA) Initiated Buy at Jones Trading; PT USD 56
• Western Midstream Partners (WES) Initiated Outperform at Mizuho; PT USD 48